• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Parameters of prostate cancer at contrast-enhanced ultrasound: correlation with prostate cancer risk.超声造影下前列腺癌的参数:与前列腺癌风险的相关性
Int J Clin Exp Med. 2015 Feb 15;8(2):2562-9. eCollection 2015.
2
Application of contrast-enhanced ultrasound in the pathological grading and prognosis prediction of hepatocellular carcinoma.超声造影在肝细胞癌病理分级及预后预测中的应用
Transl Cancer Res. 2021 Sep;10(9):4106-4115. doi: 10.21037/tcr-21-1264.
3
Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.对比增强超声(CEUS)与MRI图像融合用于监测高强度聚焦超声(HIFU)治疗前列腺癌的局部治疗1。
Clin Hemorheol Microcirc. 2018;69(1-2):93-100. doi: 10.3233/CH-189123.
4
Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury Using Contrast-Enhanced Ultrasound.使用超声造影对兔肝脏缺血再灌注损伤后肝微循环的定量分析
Ultrasound Med Biol. 2017 Oct;43(10):2469-2476. doi: 10.1016/j.ultrasmedbio.2017.06.004. Epub 2017 Jul 3.
5
Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy?定量对比增强超声检查能否预测宫颈癌新辅助化疗的疗效?
Eur J Radiol. 2016 Nov;85(11):2111-2118. doi: 10.1016/j.ejrad.2016.09.025. Epub 2016 Sep 25.
6
Value of Perfusion Parameters for Differentiating Hepatocellular Carcinoma and Liver Metastasis With Hypervascularity and a Normal Hepatic Background on Contrast-Enhanced Ultrasound Imaging.超声造影增强成像背景正常肝实质中高血供肝细胞癌与肝转移瘤的灌注参数鉴别价值。
J Ultrasound Med. 2019 Oct;38(10):2601-2608. doi: 10.1002/jum.14957. Epub 2019 Jan 30.
7
Follow-up after focal therapy of the prostate with high intensity focused ultrasound (HIFU) using contrast enhanced ultrasound (CEUS) in combination with MRI image fusion.经高强度聚焦超声(HIFU)治疗前列腺后的随访,采用对比增强超声(CEUS)联合 MRI 图像融合。
Clin Hemorheol Microcirc. 2019;73(1):135-143. doi: 10.3233/CH-199222.
8
[Values of the Quantitative Parameters of Contrast-enhanced Ultrasound in the Diagnosis of Thyroid Benign and Malignant Nodules].[超声造影定量参数在甲状腺良恶性结节诊断中的价值]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020 Feb 28;42(1):80-85. doi: 10.3881/j.issn.1000-503X.11269.
9
A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.直接比较超声造影和动态对比增强磁共振成像在前列腺癌检测和侵袭性预测中的应用。
Eur Radiol. 2018 May;28(5):1949-1960. doi: 10.1007/s00330-017-5192-2. Epub 2017 Dec 13.
10
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

引用本文的文献

1
The diagnostic value of two-dimensional ultrasound score, contrast-enhanced ultrasound score and ultrasound elastography score in prostate cancer.二维超声评分、超声造影评分及超声弹性成像评分在前列腺癌中的诊断价值
Transl Androl Urol. 2024 Sep 30;13(9):1805-1813. doi: 10.21037/tau-24-137. Epub 2024 Sep 26.
2
Towards reliable diagnostics of prostate cancer via breath.通过呼吸实现前列腺癌可靠诊断。
Sci Rep. 2021 Sep 15;11(1):18381. doi: 10.1038/s41598-021-96845-z.
3
Contrast-enhanced transrectal ultrasound can reduce collection of unnecessary biopsies when diagnosing prostate cancer and is predictive of biochemical recurrence following a radical prostatectomy in patients with localized prostate cancer.经直肠对比增强超声有助于减少前列腺癌诊断时不必要的活检,且对于局限性前列腺癌患者行根治性前列腺切除术后生化复发具有预测价值。
BMC Urol. 2020 Jul 16;20(1):100. doi: 10.1186/s12894-020-00659-6.
4
Contrast-Enhanced Transrectal Ultrasound for Follow-up After Focal HIFU Ablation for Prostate Cancer.对比增强经直肠超声用于前列腺癌局灶性高强度聚焦超声消融术后的随访
J Ultrasound Med. 2019 Mar;38(3):811-819. doi: 10.1002/jum.14765. Epub 2018 Aug 16.
5
Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer.血管内皮生长因子抑制人前列腺癌树突状细胞的功能。
Onco Targets Ther. 2018 Mar 6;11:1267-1274. doi: 10.2147/OTT.S161302. eCollection 2018.

本文引用的文献

1
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.EAU 前列腺癌指南。第 1 部分:筛查、诊断和以治愈为目的的局部治疗——2013 年更新。
Eur Urol. 2014 Jan;65(1):124-37. doi: 10.1016/j.eururo.2013.09.046. Epub 2013 Oct 6.
2
First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results.应用对比增强超声(CEUS)评估恶性前列腺肿瘤微血管化的腔内初步结果:初步结果。
Clin Hemorheol Microcirc. 2012;52(2-4):167-77. doi: 10.3233/CH-2012-1594.
3
A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam.初筛阴性 4 年后前列腺癌风险计算器:ERSPC 鹿特丹研究结果。
Eur Urol. 2013 Apr;63(4):627-33. doi: 10.1016/j.eururo.2012.07.029. Epub 2012 Jul 20.
4
Cancer incidence among patients of the U.S. Veterans Affairs Health Care System.美国退伍军人事务部医疗保健系统患者中的癌症发病率。
Mil Med. 2012 Jun;177(6):693-701. doi: 10.7205/milmed-d-11-00434.
5
Usefulness of perflubutane microbubble-enhanced ultrasound in imaging and detection of prostate cancer: phase II multicenter clinical trial.微泡增强超声在前列腺癌成像和检测中的应用:Ⅱ期多中心临床试验。
World J Urol. 2013 Oct;31(5):1123-8. doi: 10.1007/s00345-012-0833-1. Epub 2012 Feb 4.
6
Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging.评估肝细胞癌的动脉血供丰富程度:超声造影与钆塞酸二钠增强磁共振成像的比较。
Eur Radiol. 2012 Jun;22(6):1205-13. doi: 10.1007/s00330-011-2372-3. Epub 2012 Jan 24.
7
Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.前列腺癌的弥散加权和动态对比增强 MRI:定量 MR 参数与 Gleason 评分和肿瘤血管生成的相关性。
AJR Am J Roentgenol. 2011 Dec;197(6):1382-90. doi: 10.2214/AJR.11.6861.
8
Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.前列腺癌风险预测:前列腺体积和直肠指检在 ERSPC 风险计算器中的作用。
Eur Urol. 2012 Mar;61(3):577-83. doi: 10.1016/j.eururo.2011.11.012. Epub 2011 Nov 15.
9
Evaluation of renal masses with contrast-enhanced ultrasound: initial experience.增强超声评估肾肿块:初步经验。
AJR Am J Roentgenol. 2011 Oct;197(4):897-906. doi: 10.2214/AJR.10.6330.
10
Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort.前瞻性评估使用 3-T 扩散加权磁共振成像引导活检与系统的 10 核经直肠超声前列腺活检队列对前列腺癌侵袭性的影响。
Eur Urol. 2012 Jan;61(1):177-84. doi: 10.1016/j.eururo.2011.08.042. Epub 2011 Aug 27.

超声造影下前列腺癌的参数:与前列腺癌风险的相关性

Parameters of prostate cancer at contrast-enhanced ultrasound: correlation with prostate cancer risk.

作者信息

Xu Guang, Wu Jian, Yao Ming-Hua, Yao Xu-Dong, Peng Bo, Wei Qing, Xu Hui-Xiong, Wu Rong

机构信息

Department of Medical Ultrasound, Shanghai Tenth People's Hospital, Tongji University School of Medicine Shanghai 200072, China.

Department of Urology, Shanghai Tenth People's Hospital, Tongji University School of Medicine Shanghai 200072, China.

出版信息

Int J Clin Exp Med. 2015 Feb 15;8(2):2562-9. eCollection 2015.

PMID:25932202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4402849/
Abstract

OBJECTIVE

to investigate the correlation between the parameters of prostate cancer (PCa) at contrast-enhanced ultrasound (CEUS) with PCa risk.

METHODS

84 patients (68 ± 8 years; range, 33-79 years) who had undergone CEUS were included. All the images were offline analyzed. Parameters (maximum intensity (IMAX), rise time (RT), time to peak (TTP) and mean transit time (mTT)) were recorded and compared with PSA level, Gleason score, clinical stages and PCa risk.

RESULTS

Age was correlated significantly with PCa risk. RT and mTT of outer gland were associated with PCa risk. No significant correlation was found between PSA and CEUS enhancement parameters. Furthermore, with the exception of IMAX of inner gland and IMAX of outer gland, there were no significant differences of enhancement parameters in Gleason score groups and clinical stages groups.

CONCLUSION

The enhancement parameters of PCa at CEUS may be used to predict PCa risk. And it is helpful for the choice of therapeutic options.

摘要

目的

探讨前列腺癌(PCa)在超声造影(CEUS)下的参数与PCa风险之间的相关性。

方法

纳入84例行CEUS检查的患者(年龄68±8岁;范围33 - 79岁)。所有图像均进行离线分析。记录参数(最大强度(IMAX)、上升时间(RT)、达峰时间(TTP)和平均通过时间(mTT)),并与前列腺特异性抗原(PSA)水平、 Gleason评分、临床分期及PCa风险进行比较。

结果

年龄与PCa风险显著相关。外腺的RT和mTT与PCa风险相关。PSA与CEUS增强参数之间未发现显著相关性。此外,除内腺IMAX和外腺IMAX外,Gleason评分组和临床分期组的增强参数无显著差异。

结论

CEUS下PCa的增强参数可用于预测PCa风险。这有助于治疗方案的选择。